4.7 Article

A genomic approach identifies sRAGE as a putatively causal protein for asthma

Related references

Note: Only part of the references are listed.
Article Immunology

sRAGE Inhibits the Mucus Hypersecretion in a Mouse Model with Neutrophilic Asthma

Xiaobo Zhang et al.

Summary: The study found that sRAGE may be a potential target for the treatment of mucus hypersecretion in Neutrophilic asthma. AAV9-sRAGE effectively reduced collagen deposition, PAS score, and the expression of MUC5AC and MUC5B.

IMMUNOLOGICAL INVESTIGATIONS (2022)

Article Neurosciences

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients

Aleksandra Damasiewicz-Bodzek et al.

Summary: The study found that serum AGE concentration was higher and sRAGE concentration was lower in multiple sclerosis (MS) patients compared to healthy controls, but the differences were not statistically significant. In MS patients, serum AGE and sRAGE concentrations did not differ significantly based on disease duration and EDSS score.

BRAIN SCIENCES (2021)

Article Genetics & Heredity

Power calculation for the general two-sample Mendelian randomization analysis

Lu Deng et al.

GENETIC EPIDEMIOLOGY (2020)

Article Endocrinology & Metabolism

Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis

R. M. Ruggeri et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2020)

Review Biotechnology & Applied Microbiology

Pathological Implications of Receptor for Advanced Glycation End-Product (AGER) Gene Polymorphism

Marine Serveaux-Dancer et al.

DISEASE MARKERS (2019)

Article Allergy

The receptor for advanced glycation end products is a critical mediator of type 2 cytokine signaling in the lungs

Timothy N. Perkins et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Respiratory System

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial

Bartolome R. Celli et al.

BMJ OPEN RESPIRATORY RESEARCH (2019)

Review Medicine, Research & Experimental

Targeting RAGE Signaling in Inflammatory Disease

Barry I. Hudson et al.

ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)

Article Cardiac & Cardiovascular Systems

Protein Biomarkers of Cardiovascular Disease and Mortality in the Community

Jennifer E. Ho et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

Article Multidisciplinary Sciences

Genomic atlas of the human plasma proteome

Benjamin B. Sun et al.

NATURE (2018)

Review Public, Environmental & Occupational Health

Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants

Stephen Burgess et al.

EPIDEMIOLOGY (2017)

Article Endocrinology & Metabolism

Decreased Level of sRAGE in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset

Anton Glasnovic et al.

NEUROIMMUNOMODULATION (2014)

Article Respiratory System

Soluble RAGE is deficient in neutrophilic asthma and COPD

M. B. Sukkar et al.

EUROPEAN RESPIRATORY JOURNAL (2012)

Article Allergy

A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study

Mark Granada et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Article Pharmacology & Pharmacy

Soluble RAGE-Modulating Drugs: State-of-the-Art and Future Perspectives for Targeting Vascular Inflammation

Niccolo Lanati et al.

CURRENT VASCULAR PHARMACOLOGY (2010)

Review Mathematical & Computational Biology

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

Debbie A. Lawlor et al.

STATISTICS IN MEDICINE (2008)

Review Respiratory System

Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma

G Horvath et al.

EUROPEAN RESPIRATORY JOURNAL (2006)

Article Respiratory System

Elevation of total serum immunoglobulin E is associated with asthma in nonallergic individuals

KM Beeh et al.

EUROPEAN RESPIRATORY JOURNAL (2000)